drugset / Trial / NCT06674915
Investigation of Pharmacokinetics,Safety,and Pharmacodynamics of HRS-5965 in Subjects With Hepatic Impairment
Non-randomizedParallel-groupOpen-labelTreatment
Summary
The study is being conducted to compare the pharmacokinetics, safety, and pharmacodynamics of HRS-5965 in subjects with mild to moderate hepatic impairment and normal hepatic function.
Timeline
- Start
- 2024-11-26
- Primary completion
- 2026-01-16
- Completion
- 2026-01-16
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | HRS-5965 | Small molecule | 50 mg | Oral |